The NKTR chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the NKTR chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The NKTR stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View NKTR Detailed Price Forecast - CNN Money||View NKTR Detailed Summary - Google Finance|
|View NKTR Detailed Summary - Yahoo! Finance||View NKTR Stock Research & Analysis - Zacks.com|
|View NKTR Trends & Analysis - Trade-Ideas||View NKTR Major Holders - Barrons|
|View NKTR Call Transcripts - NASDAQ||View NKTR Breaking News & Analysis - Seeking Alpha|
|View NKTR Annual Report - CompanySpotlight.com||View NKTR OTC Short Report - OTCShortReport.com|
|View NKTR Fundamentals - TradeKing||View NKTR SEC Filings - Bar Chart|
|View Historical Prices for NKTR - The WSJ||View Performance/Total Return for NKTR - Morningstar|
|View the Analyst Estimates for NKTR - MarketWatch||View the Earnings History for NKTR - CNBC|
|View the NKTR Earnings - StockMarketWatch||View NKTR Buy or Sell Recommendations - MacroAxis|
|View the NKTR Bullish Patterns - American Bulls||View NKTR Short Pain Metrics - ShortPainBot.com|
|View NKTR Stock Mentions - StockTwits||View NKTR Stock Mentions - PennyStockTweets|
|View NKTR Stock Mentions - Twitter||View NKTR Investment Forum News - Investor Hub|
|View NKTR Stock Mentions - Yahoo! Message Board||View NKTR Stock Mentions - Seeking Alpha|
|View Insider Transactions for NKTR - SECform4.com||View Insider Transactions for NKTR - Insider Cow|
|View NKTR Major Holdings Summary - CNBC||View Insider Disclosure for NKTR - OTC Markets|
|View Insider Transactions for NKTR - Yahoo! Finance||View Institutional Holdings for NKTR - NASDAQ|
|View NKTR Stock Insight & Charts - FinViz.com||View NKTR Investment Charts - StockCharts.com|
|View NKTR Stock Overview & Charts - BarChart||View NKTR User Generated Charts - Trading View|
Is Nektar Therapeutics Still a Good Bet Despite the Correction?
Posted on Thursday June 21, 2018
Nektar Therapeutics (NASDAQ: NKTR) is a clinical-stage biotech research company that develops drugs for cancer, auto-immune diseases, and chronic pain using its PEGylation and polymer conjugate technology platforms. Earlier in Feb 2018, Nektar secured a deal with Bristol-Myers Squibb (NASDAQ: BMY) to co-develop NKTR-214, where BMY has agreed to pay $1.85 billion in a cash plus stock deal as payment to Nektar, as a result of which Nektar has not failed to leave investors’ radar. Here we use TipRanks data to take a closer look at what Wall Street’s top analysts see in store for this volatile stock.
Nektar Is the One S&P 500 Company Without a Woman Director
Posted on Tuesday June 19, 2018
is the only S&P 500 company without a woman on its board, representing a small improvement in gender diversity from last year. According to a May 31 dataset compiled by BoardEx, a relationship mapping service of TheStreet Inc., San Francisco-based Nektar has no female directors on its board. Meanwhile, eight S&P 500 companies have reached gender parity or greater in the boardroom, including Alliant Energy Corp.
Today's Research Reports on Trending Tickers: Verastem and Nektar Therapeutics
Posted on Monday June 18, 2018
NEW YORK, NY / ACCESSWIRE / June 18, 2018 / U.S. market plunged on Friday, but well-off session lows as investors appeared to look at previous signs of escalating trade tension between Washington and Beijing. ...
Nektar Therapeutics Closed Higher on June 14
Posted on Friday June 15, 2018
The S&P 500’s top gainers on June 14 were: Nektar Therapeutics (NKTR) gained 5.5%. Royal Caribbean Cruises (RCL) gained 5.1%. Comcast Corp A (CMCSA) gained 4.6%. Discovery Comm A (DISCA) gained 4.5%. Incyte (INCY) gained 4.4%. Nektar Therapeutics